Drug efficacy and safety data
for every trial

Talk to our team

‍Safety and efficacy data from every time point of every trial for every drug.

Trial design and eligibility criteria for every trial, structured for easy filtering.

All the data you need to figure out how good a drug needs to be to succeed

No more hunting down numbers in dozens of papers, posters, and investor decks

Meet the team

Leadership

Lukas Kidzinski

Lukas Kidzinski

Co-founder
Ex-Director of AI at Clario
Stanford University Researcher

Kevin Thomas

Kevin Thomas

Co-founder
Ex-Director of AI at Clario
Stanford University PhD

Advisors and investors

Scott Delp

Scott Delp

Professor of Bioengineering
Stanford University

Dan Gebow

Dan Gebow

CEO at Recombo.ai
Ex-SVP of Product at Oracle Life Sciences

Robert Bogucki

Robert Bogucki

Director at Google
Ex-CEO of deepsense.ai
(investor)

How to use Gosset?

Learn how to leverage Gosset's features through our brief tutorial series

Loading tutorial videos...

Selected features

Gosset is engineered for optimal capital allocation

Drugs under development

Get every drug in active development for your disease of interest, along with safety and efficacy results data from each trial. See placebo performance and structured eligibility criteria too.

Standard-of-care drugs

Get every standard-of-care drug for your disease of interest, along with their safety and efficacy data from each trial.

Results data for every clinical trial

We hunt down the results for every trial from research papers, conference posters, investor decks, press releases, etc. No one else offers this - not Evaluate, Cortellis, Global Data, or ClinicalTrials.Gov. All data is verified by a real person.

Data available via dashboard, spreadsheet, or API

Get insights quickly via interactive graphs and filterable tables in our dashboard, or work with the data directly with our comprehensive spreadsheets or API.

Latest Updates from LinkedIn

Stay connected with our latest news, insights, and industry updates.

Engineered for optimal capital allocation

Investors

Related Companies

Corporate development

Comprehensive head-to-head drug comparison data. Nuanced competitive landscape analyses for venture capital and private equity. Analysis of catalyst events and options activity for public markets.

Ready to get started? Contact us or create an account